Skip to main content
. 2019 Autumn;18(4):1694–1703. doi: 10.22037/ijpr.2019.14050.12131

Figure 2.

Figure 2

Viability (%) of MCF-7 cells of various treatment groups after 48 h incubation. The concentrations of formulations are equivalent to the concentration of 0.01 µM to 10.3 µM of gemcitabine (24).